Fas and Fas ligand expression in tumor cells and in vascular smooth- muscle cells of colonic and renal carcinomas

International Journal of Cancer

Volumn 81, Issue 5, 1999, Pages 772-778

  Eberl, Lucie Peduto ^a   Guillou, Louis ^a   Saraga, Emilia ^a   Schröter, Michael ^a   French, Lars E ^b   Tschopp, Jürg ^a   Juillerat Jeanneret, Lucienne ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; FAS LIGAND;

ANIMAL CELL; ARTICLE; COLON CARCINOMA; COLON MUCOSA; CONTROLLED STUDY; EPITHELIUM CELL; HENLE LOOP; HUMAN; HUMAN CELL; HUMAN TISSUE; INTESTINE CRYPT; KIDNEY CARCINOMA; KIDNEY PROXIMAL TUBULE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SMOOTH MUSCLE FIBER; TUMOR ASSOCIATED LEUKOCYTE; TUMOR CELL; VASCULAR SMOOTH MUSCLE;

ADENOCARCINOMA; ANIMALS; ANTIGENS, CD95; BLOTTING, WESTERN; CARCINOMA, RENAL CELL; COLON; COLONIC NEOPLASMS; FAS LIGAND PROTEIN; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; INTESTINAL MUCOSA; KIDNEY; KIDNEY NEOPLASMS; MEMBRANE GLYCOPROTEINS; MUSCLE, SMOOTH, VASCULAR; RATS; TUMOR CELLS, CULTURED;

EID: 0345517340     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19990531)81:5<772::AID-IJC18>3.0.CO;2-S     Document Type: Article

References (23)

1. BRUNNER, T., MOGIL, R.J., LAFACE, D., YOO, N.J., MAHBOUDI, A., ECHEVERRI, V., MARTIN, S., FORCE, W.S., LYNCH, D.H., WARE, C.V. and GREEN, D., Cell-autonomous Fas(CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature (Lond.), 373, 441-144 (1995).
2. CASCINO, I., PAPOFF, G., DE MARIA, R., TESTI, R. and RUBERTI, G., Fas/Apo-1 (CD95) receptor lacking the intracytoplasmic signaling domain protects tumor cells from Fas-mediated apoptosis. J. Immunol., 156, 13-17 (1996).
3. DAVENPORT, E.A. and NETTESHEIM, P., Type I collagen gel modulates extracellular matrix synthesis and deposition by tracheal epithelial cells. Exp. Cell Res., 223, 155-162 (1996).
4. FIDLER, I.J. and KRIPKE, M.L., Metastasis results from preexisting variant cells within a malignant tumor. Science, 197, 893-895 (1977).
5. FRENCH, L.E., HAHNE, M., VIARD, I., RADLGRUBER, G., ZANONE, R., BECKER, K., MULLER, C. and TSCHOPP, J., Fas and Fas ligand in embryos and adult mice: ligand expression in several immune-privileged tissues and coexpression in adult tissues characterized by apoptotic cell turnover. J. Cell Biol., 133, 335-343 (1996).
6. HAHNE, M., RIMOLDI, D., SCHRÖTER, M., ROMERO, P., SCHREIER, M., FRENCH, L.E., SCHNEIDER, P., BORNAND, T., FONTANA, A., LIENARD, D., CEROTTINI, J.C. and TSCHOPP, J., Melanoma cell expression of Fas (APO-1/CD95) ligand: implications for tumor immune escape. Science, 274, 1363-1366 (1996).
7. IRMLER, M. and 12 OTHERS, Inhibition of death receptor signals by cellular FLIP. Nature (Lond.), 388, 190-195 (1997).
8. ITOH, N. and NAGATA, S., A novel protein domain required for apoptosis. Mutational analysis of human Fas antigen. J. biol. Chem., 268, 10932-10937 (1993).
9. ITOH, N., YONEHARA, S., ISHII, A., YOHENARA, M., MIZUSHIMA, S., SAMESHIMA, M., HASE, A., SETO, Y. and NAGATA, S., The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell, 66, 233-243 (1991).
10. LECOEUR, H. and GOUGEON, M.L., Comparative analysis of flow-cytometric methods for apoptosis quantitation in murine thymocytes and human peripheral lymphocytes from controls and HIV-infected persons. Evidence for interference by granulocytes and erythrocytes. J. Immunol. Methods, 198, 87-99 (1996).
11. LEITHÄUSER, F., DHEIN, J., MECHTERSHEIMER, G., KORETZ, K., BRÜDERLEIN, S., HENNE, C., SCHMIDT, K.M., DEBATIN, K.M., KRAMMER, P.H. and MÖLLER, P., Constitutive and induced expression of APO-1, a new member of the nerve growth-factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells. Lab. Invest., 69, 415-429 (1993).
12. LIOTTA, L.A. and KOHN, E., Cancer invasion and metastasis. J. Am. Med. Ass., 263, 1123-1126 (1990).
13. LYNCH, D.H., RAMSDELL, F. and ALDERSON, M.R., Fas and FasL in the homeostatic regulation of immune responses. Immunol. Today, 16, 569 (1995).
14. MARTIN, F., CAIGNARD, A., JEANNIN, J.F., LECLERC, A. and MARTIN, M.S., Selection by trypsin of two sublines of rat colon-cancer cells forming progressive or regressive tumors. Int. J. Cancer, 32, 623-627 (1983).
15. MÖLLER, P., KORETZ, K., LEITHÄUSER, F., BRÜDERLEIN, S., HENNE, C., QUENTMEIER, A. and KRAMMER, P.H., Expression of APO-1 (CD95), a member of the NGF/TNF receptor superfamily, in normal and neoplastic colon epithelium. Int. J. Cancer, 57, 371-377 (1994).
16. O'CONNELL, J., BENNETT, M.W., O'SULLIVAN, G.C., COLLINS, J.K. and SHANAHAN, F., The Fas counterattack: a molecular mechanism of tumor immune privilege. Mol. Med., 3, 294-300 (1997).
17. O'CONNELL, J., O'SULLIVAN, G.C., COLLINS, J.K. and SHANAHAN, F., The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand. J. exp. Med., 184, 1075-1082 (1996).
18. ORTIZ-ARDUAN, A., DANOFF, T.M., KALLURI, R., GONZALES-CUADRADO, S., KARP, S.L., ELKON, K., EGIDO, J. and NEILSON, E.G., Regulation of Fas and Fas ligand expression in cultured murine renal cells and in the kidney during endotoxemia. Amer. J. Physiol., 271, F1193-201 (1996).
19. SAAS, P., WALKER, P.R., HAHNE, M., QUIQUEREZ, A.-L., SCHNURIGER, V., PERRIN, G., FRENCH, L.E., VAN MEIR, E.G., DE TRIBOLET, N., TSCHOPP, J. and DIETRICH, P.Y., Fas ligand expression by astrocytoma in vivo: maintaining immune privilege in the brain? J. clin. Invest., 99, 1173-1178 (1997).
20. STRAND, S., HOFMANN, W.J., HUG, H., MÜLLER, M., OTTO, G., STRAND, D., MARIANI, S.M., STREMMEL, W., KRAMMER, P.H. and GALLE, P.R., Hepatic failure and liver cell damage in acute Wilson's disease involve CD95 (APO-1/Fas) mediated apoptosis. Nature Med., 2, 1361-1366 (1996).
21. TANAKA, M. and 12 OTHERS, Fas ligand in human serum. Nature Med., 2, 317-322 (1996).
22. WATANABE-FUKUNAGA, R., BRANNAN, C.I., COPELAND, N.G., JENKINS, N.A. and NAGATA, S., Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature (Lond.), 356, 314-317 (1992).
23. WYLLIE, A.H., KERR, J.F.R. and CURRIE, A.R., Cell death: the significance of apoptosis. Int. Rev. Cytol., 68, 251-306 (1980).